Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety) Product (Readers, Kits) Technique, End User – Global Forecast to 2026

2021-12-15
Price :
Published : Dec-2021
No. of Pages : 390

The global lateral flow assays market is projected to reach USD 11.4 billion by 2026 from USD 9.6 billion in 2021, at a CAGR of 3.4% during the forecast period. The high prevalence of infectious diseases worldwide, rapid growth in the geriatric population, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices are the major factors driving the growth of this market. On the other hand, reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are the key restraints.

“Kits & Reagents segment accounted for the largest share in the lateral flow assays market.”

Based on product type, the lateral flow assays market is segmented into kits & reagents and lateral flow readers. In 2020, kits & reagents accounted for the larger share of 87.5% of the global lateral flow assays market. The large share of this segment can be attributed to the increasing application of lateral flow kits & reagents for POC testing, the growing burden of chronic diseases, the increasing use of lateral flow kits in home care, and their convenience and ease of use. The lateral flow readers segment is bifurcated into digital/handheld readers and benchtop readers. This segment is expected to grow at a higher CAGR of 7.1% during the forecast period.

“Clinical Testing segment is expected to witness the fastest growth in the forecast period.”

Based on applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The clinical testing segment accounted for the largest share of 89.3% of the lateral flow assays market in 2020. The large share of this segment can be attributed to the rising prevalence of chronic diseases, growing pressure to reduce healthcare costs, and the increasing demand for patient-centric care.

“Sandwich assays technique accounted for the largest share of lateral flow assays market in 2020”

Based on technique, the lateral flow assay kits & reagents market is segmented into competitive assays, sandwich assays, and multiplex detection assays. The sandwich assays technique dominated the lateral flow assays market with a share of 70.9% in 2020. The large share of this segment can be attributed to its better assay sensitivity and specificity and its extensive applications in the measurement of critical analytes (such as cardiac and hepatitis markers).

“Blood samples accounted for the largest share of lateral flow assays market in 2020”

Based on sample type, the clinical testing lateral flow assays market is segmented into blood, urine, saliva, and other samples. Blood samples accounted for the largest market share of 55.9% in 2020. The use of blood samples in lateral flow tests for infectious diseases such as malaria, HIV, and syphilis; the rising awareness of rapid testing solutions; and easy detection of disease antibodies from blood samples are key factors driving the growth of this segment.

“The hospitals & Clinics segment accounted for the largest share of lateral flow assays market in 2020”

Based on end users, the lateral flow assays market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and other end users. The hospitals & clinics segment accounted for the largest market share of 37.6% in 2020. Technological advancements, the increasing adoption of point-of-care testing and growing patient inclination toward fast and early diagnosis are driving the growth of the hospitals & clinics segment. The COVID-19 pandemic has also increased the demand for point-of-care testing in professional healthcare settings, further driving the growth of this market in the forecast period.

“North America accounted for the largest share of the lateral flow assays market in 2020”

The North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 38.8% of the lateral flow assays market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. However, the APAC is expected to grow at the highest CAGR of 5.8% during the forecast period. The rapidly developing healthcare industry in China and India, growth in the aging population, rising life expectancy, rising per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals & clinics to rural areas, the availability of low-cost labor for manufacturing, the presence of a favorable regulatory environment, and growing demand for home and POC testing are supporting market growth in the APAC. The current COVID-19 scenario and its high impact in the Asia Pacific (especially India) have also resulted in a high growth rate in the lateral flow assays market in this region.

A breakdown of the primary participants (supply-side) for the lateral flow assays market referred to for this report is provided below:

  • By Company Type: Tier 1–35%, Tier 2–20%, and Tier 3–45%
  • By Designation: C-level–45%, Director Level–25%, and Others–30%
  • By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, and Middle East and Africa– 7%

Some of the key players in the Lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Bio-Rad Laboratories (US), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Quidel Corporation (US), and Merck KGaA (Germany).

Research Coverage:

The market study covers the lateral flow assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product type, application by technique, by sample type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the lateral flow assays market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.

Filed in: Medical Device
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

Laboratory Centrifuges Market by Product (Equipment (Microcentrifuge, Ultracentrifuge), Accessories (Tube, Plate)), Model (Benchtop), Rotor Design (Swinging-bucket), Intended Use (Clinical), Application (Diagnostics), End User (Hospitals) – Global Forecast to 2026

“Laboratory centrifuges market is projected to grow at CAGR of 4.0% from 2021 to 2026” The global laboratory centrifuges market is projected to USD 2.2 billion by 2026 from USD 1.8 billion in 2021, at a CAGR of 4.0% from 2021 to 2026. The growth of this market is driven by increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges; and widening applications of laboratory centrifuges. Also, Integration of automation and advanced features in laboratory centrifuges and emerging economies are anticipated to offer opportunity for the growth of the market during the forecast period. “Equi......
$4950

Preparative and Process Chromatography Market by Type (Preparative (Chemicals and Reagents, Resin (Affinity, Ion Exchange), Column, Systems (Liquid Chromatography), Services), Process), End User (Research Laboratories) – Global Forecasts to 2026

“Preparative and process chromatography market is projected to grow at CAGR of 6.7% from 2021 to 2026” The global preparative and process chromatography market is projected to USD 12.8 billion by 2026 from USD 9.3 billion in 2021, at a CAGR of 6.7% from 2021 to 2026. The growth of this market is driven by the increasing demand for insulin and other biopharmaceutical products, high demand for omega-3 fatty acids, increasing awareness about the advancements in preparative and process chromatography, increasing food safety concerns, and growing government investments for synthetic biology and genome projects. Also, increasing demand for monoclonal antibodies, incoming advanced technologies for the purification of biopharmaceutical & biomolecule separations and chromatography instrume......
$4950

Stoma/Ostomy Care Market by Product (Bags (Surgery Type (Ileostomy, Colostomy, Urostomy), System (One, Two-Piece), Usability (Drainable, Closed), Shape (Flat, Convex)), Accessories (Powder, Deodorant)), End User and Region – Global Forecast to 2026

Growing target patient population and prevalence of inflammatory bowel diseases to drive market growth during the forecast period” The global Stoma/Ostomy Care Market is expected to reach USD 3.2 billion by 2026 from an estimated USD 2.6 billion in 2021, at a CAGR of 4.3% from 2021 to 2026. Ostomy is a surgical procedure that involves the removal of diseased portions of the gastrointestinal or urinary system, creating an opening in the abdominal wall that results in the external diversion of feces and urine. An ostomy may be permanent or temporary, and each procedure results in a stoma, which is the end of the small or large intestine that can be seen protruding through the abdominal wall. The market scope includes ostomy bags/pouches and accessories utilized by ostomates or patien......
$6780

Breast Lesion Localization Market by Type (Wire, Radioisotope (ROLL,RSL), Magnetic, Electromagnetic Localization), Usage (Breast Biopsy,Lumpectomy), End User Preference Survey (Selection Criteria, Replacement Trend) – Global Forecast to 2026

The breast lesion localization market is expected to reach USD 305 million by 2026 from USD 244 million in 2021. The growth of this market is mainly attributed to the growing incidence of breast cancer, the increasing rate of the geriatric population (as age contributes to the risk of breast cancer and the rising awareness on the early detection of breast cancer in the coming years. However, several factors, such as uncertainty in regulatory approval procedures, are expected to restrain the growth of the breast lesion localization market during the forecast period. In this report, the breast lesion localization market is segmented based on type, usage, and region. In terms of value, the wire localization segment accounted for the largest share of the breast lesion localization market......
$4950

Drug Screening Market by Product (Consumables, Urine Testing Devices, Analytical, Breathalyzer, Chromatography, Immunoassay) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) – Global Forecast to 2026

“The rising drug & alcohol consumption, and the enforcement of stringent laws mandating drug & alcohol testing are expected to drive the overall growth of the drug screening market.” The global drug screening market is projected to reach USD 11.6 billion by 2026, from USD 5.3 billion in 2021, at a CAGR of 16.8% during the forecast period. Market growth can be largely attributed to the growing drug & alcohol consumption and the enforcement of stringent laws mandating drug & alcohol testing, rising regulatory approvals for drug screening products & services. On the other hand, bans on alcohol consumption in Islamic countries and prohibitions on workplace drug testing in specific countries may hinder the growth of this market to a certain extent. “Drug screenin......
$4950

Surgical Instrument Tracking System Market with COVID-19 Impact by Technology(RFID, Barcode), Component(Hardware (Scanner, Reader, Tags), Software, Services), End User(Hospital (Public, Private)), Region – Global Forecast to 2026

“Need to meet FDA Unique Device Identification mandates are driving market growth” The surgical instrument tracking systems market is projected to reach USD 406 million by 2026 from an estimated USD 203 million in 2021, at a CAGR of 14.9% during the forecast period. Tracking systems are gaining importance among healthcare providers due to the drive to reduce costs and increase efficiency. Ensuring better inventory and asset management practices is key to this drive. End users are focused on minimizing the loss of valuable assets and ensuring smooth workflows. Other factors driving market growth include the FDA’s Unique Device Identification mandates and the growth of the surgical instruments market. However, high system costs, long investment cycles, budgetary constraints, and ......
$4950

North American Radiation Protection Apron Market by Type (Front Protection, Vest & Skirt, Full Wrap, Pregnancy Lead Apron), Material (Lead Apron, Light Lead Composite Apron, Lead Free Apron), Country (US, Canada) – Forecast to 2026

“Incerasing safety awareness among people working in the radiation-prone environments.” The North American radiation protection aprons market is projected to reach USD 48 million by 2026 from USD 35 million in 2021, at a CAGR of 6.9% during the forecast period. The growth of the North American radiation protection aprons market is being driven by factors such as increasing number of trained radiologic technologists, increasing safety awareness, the growing number of orthopedic and spine surgeries, and growth in the number of PET/CT scans. Lead aprons are deemed no longer necessary for adult patients in dental X-ray procedures in the US is expected to restrain North American radiation protection market growth. Increasing usage of nuclear medicine & radiation therapy coupled with ......
$4950

Connected Car Market by Service ICE & EV (OTA, Navigation, Cybersecurity, Multimedia Streaming, Social Media, e-Call, Autopilot, Home Integration), Form, Market (OE, Aftermarket), Network, Transponder, Hardware and Region – Global Forecast to 2026

“Increase in demand for premium and luxury vehicle and growing popularity of smartphone services and connectivity solutions in vehicles are major factors driving the growth of the connected car market globally” The global connected car market is projected to reach USD 57.6 billion by 2026 from an estimated USD 24.0 billion in 2021, at a CAGR of 19.1% from 2021 to 2026. All major carmakers, such as Ford, BMW, Audi, Volvo, Hyundai, and Toyota, offer some form of connectivity in their vehicles. Connected cars ease connectivity on wheels, offering comfort, convenience, performance, safety, and security along with powerful network technology. This enables the driver to connect with online platforms, thereby facilitating real-time communication. The rise in consumer demand for connecti......
$4950

Cold Plasma Market by Industry (Textile, Electronics & Semiconductors, Polymers & Plastic, Food & Agriculture, Medical, Others), Application (Adhesion, Printing, Wound Healing), Regime (Atmospheric, Low Pressure), COVID-19 Impact – Global Forecast to 2026

The global cold plasma market is projected to grow at a CAGR of 15.0% The global cold plasma market size is expected to reach USD 3.3 billion by 2026 from USD 1.6 billion in 2021, at a CAGR of 15.0% during the forecast period. The growth in this market is primarily attributed to the benefits of cold plasma, such as its environment-friendliness, increasing use of cold plasma in wound healing and cancer treatment, innovations in textile production, growing food safety concerns, innovations in cold plasma technology, and the increasing use of cold plasma in meat and poultry packaging decontamination. By polymer & plastic industry, the surface treatment segment accounted for the largest market share of the market Within the polymer & plastic industry, the cold plasma market ha......
$4950

Veterinary Imaging Market by Product (Ultrasound (2D, 3D, Doppler), X-Ray (CR, DR), MRI, CT, Software, Reagent), Therapeutic Area (Orthopedics, Gynecology, Oncology, Dentistry), Animal (Small, Large), End User (Hospital, Clinic) – Global Forecast to 2026

The veterinary imaging market is expected to grow at a CAGR of 7.0% in the forecast period. Over the years, the global veterinary imaging market has evolved from the use of diagnostic imaging instruments for human medicine to the development of specialized imaging modalities for veterinary applications. The increasing development of portable and battery-powered imaging instruments for point-of-care services, growing consolidation among veterinary practitioners, and the growing size of veterinary businesses in the veterinary imaging market are the leading trends in this market. The veterinary imaging market is expected to reach USD 2.3 billion by 2026 from an estimated USD 1.6 billion in 2021, at a CAGR of 7.0%. In this report, the veterinary imaging market is segmented based on produ......
$4950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy